Scrip's Five Must-Know Things - Oct. 6, 2025
Update: 2025-10-06
Description
Audio roundup of selected biopharma industry content from Scrip over the business week ended October 3, 2025. In this episode: Pfizer’s backroom US pricing deal; confusion over Japan’s pharma tariffs; more direct-to-patient schemes in the US; first approval for Novartis’s remibrutinib; and GSK’s CEO to step down.
Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-NYTAMV4KPFCB3PSCCQMKIF2CEA/
This episode was produced with the help of AI text-to-voice and voice emulation tools.
Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-NYTAMV4KPFCB3PSCCQMKIF2CEA/
This episode was produced with the help of AI text-to-voice and voice emulation tools.
Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
